Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement
22 août 2013 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 22, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announces its intent to close a private placement of up...
Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference
28 mai 2013 09h00 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - May 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at...
Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference
21 mai 2013 09h33 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 21, 2013) - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein,...
Stellar Biotechnologies Announces Publication of "Expert Review" Article on Clostridium Difficile Vaccines
30 avr. 2013 09h00 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - Apr 30, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole...
Stellar Biotechnologies Submits Biological Master File to U.S. FDA for Subunit KLH
19 mars 2013 09h15 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 19, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...
Stellar Biotechnologies Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter
13 mars 2013 09h10 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of results from a...
Stellar Biotechnologies Exceeds Aquaculture Capacity Goals
19 févr. 2013 08h05 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 19, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan...
Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations
06 févr. 2013 10h36 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 6, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has submitted a...
Stellar Biotechnologies to Present at Noble Financial Capital Markets Ninth Annual Equity Conference January 23, 2013
17 janv. 2013 09h35 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 18, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...
Stellar Biotechnologies, Inc. to Host Conference Call at 2:30 pm ET on Tuesday, December 18, 2012 to Provide Business Overview
12 déc. 2012 09h05 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 12, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...